GOOD NEWS! Moderna’s combination COVID/influenza vaccine candidate mRNA-1083 has OUTPERFORMED the current standalone vaccines for BOTH viruses in a large (8000+) Phase III trial. A combination vaccine would make it easier for people to get vaccinated against COVID and influenza at the same time. 🧪🧵⬇️
These are great data to see! Any idea on how long it may take to expand this trial to other age groups, i.e. under 50? Considering it’s Phase 3, I imagine not long?
Replies
-
It shouldn’t be too long at all! Especially with regulatory approval scheduled for 2026 we will likely see more data later this year!